Target: studentesse e studenti di CdS triennali
Lingua: eng
Il corso appartiene ad una serie?: Yes
Breve Descrizione:

This introductory MOOC provides a comprehensive overview of adoptive T-cell immunotherapy, with a particular focus on chimeric antigen receptor (CAR) T-cell therapy. Through twelve concise video lectures, learners will explore the biological principles underlying T-cell immunity, CAR design, manufacturing, mechanisms of action, clinical applications, treatment-related toxicities, and emerging next-generation cellular immunotherapies. The course is designed for students approaching cellular immunotherapy for the first time and provides the foundational knowledge required for the subsequent MOOCs in the series.

Informazioni Base:

The course is organized into 12 modules, each consisting of a 10-minute video lecture, accompanying slides, and a short formative quiz designed to reinforce the concepts presented.

Module 1 – Introduction to Adoptive T-Cell Immunotherapy

Module 2 – T-Cell Biology for Immunotherapy

Module 3 – Structure and Design of CARs

Module 4 – CAR-T Manufacturing

Module 5 – Approved CAR-T Therapies

Module 6 – Mechanisms of CAR-T Function

Module 7 – Resistance to CAR-T Therapy

Module 8 – Toxicities of CAR-T Therapy

Module 9 – Gene Editing and Next-Generation CAR-T Cells

Module 10 – Beyond CAR-T Cells

Module 11 – CAR-T Cells in Solid Tumors

Module 12 – Future Directions in Cellular Immunotherapy

Each module includes:

  • one video lecture (~10 minutes)
  • downloadable slides
  • a formative quiz (3–5 questions)

The course concludes with a comprehensive final assessment consisting of 12 integrative questions (one per module), different from those presented during the course.

Risultati Attesi:

 Upon successful completion of this MOOC, the learner will be able to:

  1. Describe the fundamental principles of adaptive immunity and T-cell biology in the context of cellular immunotherapy. 

  2. Identify the structural components of chimeric antigen receptors and explain their respective biological functions. 

  3. Illustrate the major steps involved in the manufacturing process of CAR-T cell products. 

  4. Differentiate currently approved CAR-T cell therapies according to their indications and target antigens. 

  5. Explain the cellular and molecular mechanisms responsible for CAR-T cell activation, expansion, persistence, and tumor elimination. 

  6. Recognize the principal mechanisms of resistance that limit the efficacy of CAR-T cell therapy. 

  7. Identify the major toxicities associated with CAR-T cell therapy and describe their biological basis. 

  8. Compare current and emerging cellular immunotherapy platforms, including next-generation engineered immune cells. 

  9. Discuss future directions in cellular immunotherapy, including gene editing, synthetic biology, and novel therapeutic strategies.

Strategia di valutazione:

Quiz Assessment

Prerequisiti:

No prior knowledge of CAR-T cell therapy is required.

Learners are expected to possess basic undergraduate-level knowledge of:

  • cell biology 

  • molecular biology 

  • immunology 

This MOOC serves as the entry point to the series and is recommended before enrolling in:

  • Translational Innovations in CAR-T Cell Therapy 

  • Clinical Advances and Transformative Programs in CAR-T Therapy

Livello EQF: EQF Level 6
ISCED-F: 0912 Medicine
Categoria: Salute e Medicina
SDGs: GOOD HEALTH AND WELLBEING
Docenti:

Marco Ruella

Carico Lavoro Totale (in ore/settimana): 6
Numero settimane del corso: 1
Contatti:

marco.ruella@unito.it

For technical issues: 

edvancedeh@unito.it